TY - JOUR
T1 - Correlates of the molecular vaginal microbiota composition of African women
AU - Vaginal Biomarkers Study Group
AU - Gautam, Raju
AU - Borgdorff, Hanneke
AU - Jespers, Vicky
AU - Francis, Suzanna C.
AU - Verhelst, Rita
AU - Mwaura, Mary
AU - Delany-Moretlwe, Sinead
AU - Ndayisaba, Gilles
AU - Kyongo, Jordan K.
AU - Hardy, Liselotte
AU - Menten, Joris
AU - Crucitti, Tania
AU - Tsivtsivadze, Evgeni
AU - Schuren, Frank
AU - van de Wijgert, Janneke H.H.M.
AU - Mandaliya, Kishor
AU - Dierick, Lou
AU - Jaoko, Walter
AU - Irungu, Eunice
AU - Katingima, Christine
AU - Maina, Mercy
AU - Mazera, Jane Wanjiru
AU - Gichuru, Josephine
AU - Onuki, Grace Aketch
AU - Kiambi, Mary
AU - Thiong'o, Mary
AU - Wanjiku, Salome
AU - Nduku, Patricia
AU - Njeru, Carol
AU - Mbogho, Bernard
AU - Wambua, Sammy
AU - Baya, Rachel Sidi
AU - Onduko, Emmanuel Moffat
AU - Kombo, Patrick Katana
AU - Masha, Simon Chengo
AU - Ndinda, Mary
AU - Odeyo, John Kevin
AU - Ngala, Dora
AU - Odero, Collins
AU - Edward, Vinodh Aroon
AU - Reddy, Krishnaveni
AU - Von Knorring, Nina
AU - Mahabeer, Ishania
AU - Mashilo, Johannah Nkoleleng
AU - Mnyandu, Ntombifuthi
AU - Mokoatle, Keneuoe
AU - Nani, Siyabulela
AU - Tshabalala, Gugu
AU - Mngwevu, Thembisile Hope
AU - Temmerman, Marleen
N1 - Publisher Copyright:
© 2015 Gautam et al.
PY - 2015/2/11
Y1 - 2015/2/11
N2 - Background: Sociodemographic, behavioral and clinical correlates of the vaginal microbiome (VMB) as characterized by molecular methods have not been adequately studied. VMB dominated by bacteria other than lactobacilli may cause inflammation, which may facilitate HIV acquisition and other adverse reproductive health outcomes. Methods: We characterized the VMB of women in Kenya, Rwanda, South Africa and Tanzania (KRST) using a 16S rDNA phylogenetic microarray. Cytokines were quantified in cervicovaginal lavages. Potential sociodemographic, behavioral, and clinical correlates were also evaluated. Results: Three hundred thirteen samples from 230 women were available for analysis. Five VMB clusters were identified: one cluster each dominated by Lactobacillus crispatus (KRST-I) and L. iners (KRST-II), and three clusters not dominated by a single species but containing multiple (facultative) anaerobes (KRST-III/IV/V). Women in clusters KRST-I and II had lower mean concentrations of interleukin (IL)-1α (p < 0.001) and Granulocyte Colony Stimulating Factor (G-CSF) (p = 0.01), but higher concentrations of interferon-γ-induced protein (IP-10) (p < 0.01) than women in clusters KRST-III/IV/V. A lower proportion of women in cluster KRST-I tested positive for bacterial sexually transmitted infections (STIs; ptrend = 0.07) and urinary tract infection (UTI; p = 0.06), and a higher proportion of women in clusters KRST-I and II had vaginal candidiasis (ptrend = 0.09), but these associations did not reach statistical significance. Women who reported unusual vaginal discharge were more likely to belong to clusters KRST-III/IV/V (p = 0.05). Conclusion: Vaginal dysbiosis in African women was significantly associated with vaginal inflammation; the associations with increased prevalence of STIs and UTI, and decreased prevalence of vaginal candidiasis, should be confirmed in larger studies.
AB - Background: Sociodemographic, behavioral and clinical correlates of the vaginal microbiome (VMB) as characterized by molecular methods have not been adequately studied. VMB dominated by bacteria other than lactobacilli may cause inflammation, which may facilitate HIV acquisition and other adverse reproductive health outcomes. Methods: We characterized the VMB of women in Kenya, Rwanda, South Africa and Tanzania (KRST) using a 16S rDNA phylogenetic microarray. Cytokines were quantified in cervicovaginal lavages. Potential sociodemographic, behavioral, and clinical correlates were also evaluated. Results: Three hundred thirteen samples from 230 women were available for analysis. Five VMB clusters were identified: one cluster each dominated by Lactobacillus crispatus (KRST-I) and L. iners (KRST-II), and three clusters not dominated by a single species but containing multiple (facultative) anaerobes (KRST-III/IV/V). Women in clusters KRST-I and II had lower mean concentrations of interleukin (IL)-1α (p < 0.001) and Granulocyte Colony Stimulating Factor (G-CSF) (p = 0.01), but higher concentrations of interferon-γ-induced protein (IP-10) (p < 0.01) than women in clusters KRST-III/IV/V. A lower proportion of women in cluster KRST-I tested positive for bacterial sexually transmitted infections (STIs; ptrend = 0.07) and urinary tract infection (UTI; p = 0.06), and a higher proportion of women in clusters KRST-I and II had vaginal candidiasis (ptrend = 0.09), but these associations did not reach statistical significance. Women who reported unusual vaginal discharge were more likely to belong to clusters KRST-III/IV/V (p = 0.05). Conclusion: Vaginal dysbiosis in African women was significantly associated with vaginal inflammation; the associations with increased prevalence of STIs and UTI, and decreased prevalence of vaginal candidiasis, should be confirmed in larger studies.
KW - Africa
KW - Bacterial vaginosis
KW - Candidiasis
KW - HIV
KW - Lactobacillus
KW - Sexually transmitted infections
KW - Urinary tract infections
KW - Vaginal microbiome
KW - Vaginal microbiota
KW - Women
UR - http://www.scopus.com/inward/record.url?scp=84925382154&partnerID=8YFLogxK
U2 - 10.1186/s12879-015-0831-1
DO - 10.1186/s12879-015-0831-1
M3 - Article
C2 - 25887567
AN - SCOPUS:84925382154
SN - 1471-2334
VL - 15
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
IS - 1
M1 - 86
ER -